Cantor Fitzgerald raised the firm’s price target on Omega Healthcare (OHI) to $52 from $50 and keeps an Overweight rating on the shares. Omega Healthcare delivered strong external growth and improved rent coverage in 2025 and has begun 2026 with over $200M in completed investments, the analyst tells investors in a research note. With accretive capital deployment, potential guidance increases, and beatable 2026-2027 growth assumptions, the outlook points to an eventful year with upside to estimates, the firm says.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare Investors: Rising Operational and Earnings Risk as RIDEA Expansion Increases Dependence on Third-Party Managers
- Omega Healthcare Investors Signals Confident 2026 Earnings Path
- Omega Healthcare price target raised to $52 from $51 at UBS
- Omega Healthcare sees FY26 AFFO $3.15-$3.25, consensus $3.26
- Omega Healthcare reports Q4 AFFO 80c, consensus 79c